This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Understanding when to start thinking about retirement can make a big difference. Explore key factors to help you plan effectively.
24,441 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Walmart stock has climbed substantially in 2026, but with earnings coming up, investors want to know if the rally is ...
A dramatic 41% weekly jump has investors buzzing about Infleqtion. Learn what fueled the move, how to evaluate quantu...
A nationwide $1 million cap on home equity for Medicaid long-term care applicants will reshape eligibility rules and ...
A new analysis argues zero-down FHA loans for first-time buyers could be feasible with proper underwriting and pricin...
A new Solana-based utility token kicked off Phase 1 of its presale with a fixed price and a $0.50 listing target, as ...
Anthropic's public listing signals a new wave of AI investment. This piece highlights which major tech names could ri...
KORU, a triple-leveraged bet on South Korea stocks, sank 42% in a single trading day as chipmakers slid and risk appe...
Anthropic moves to publicly release its first Mythos-class model with Fable 5, while limiting Mythos 5 to partners. T...
SpaceX’s public debut could bring huge hype and big risks for everyday investors. This guide breaks down the mechanic...
Two 2x levered SMCI ETFs are delivering divergent outcomes in mid-2026 as AI server demand fluctuates and governance ...
SpaceX rolls out a $60 billion bid to acquire Cursor and back new silicon ventures, aiming to tilt the AI hardware la...